These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9440752)

  • 1. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
    Steyerberg EW; Gerl A; Fossá SD; Sleijfer DT; de Wit R; Kirkels WJ; Schmeller N; Clemm C; Habbema JD; Keizer HJ
    J Clin Oncol; 1998 Jan; 16(1):269-74. PubMed ID: 9440752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
    Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Toner GC; Schraffordt Koops H; Mulders PF; Messemer JE; Ney K; Donohue JP
    J Clin Oncol; 1995 May; 13(5):1177-87. PubMed ID: 7537801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
    Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW; Keizer HJ; Sleijfer DT; Fossâ SD; Bajorin DF; Gerl A; de Wit R; Kirkels WJ; Koops HS; Habbema JD
    Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
    Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
    J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer.
    Vergouwe Y; Steyerberg EW; Foster RS; Habbema JD; Donohue JP
    J Urol; 2001 Jan; 165(1):84-8; discussion 88. PubMed ID: 11125370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer.
    Fosså SD; Ous S; Lien HH; Stenwig AE
    J Urol; 1989 Mar; 141(3):557-9. PubMed ID: 2918591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
    Beck SD; Foster RS; Bihrle R; Ulbright T; Koch MO; Wahle GR; Einhorn LH; Donohue JP
    J Urol; 2002 Oct; 168(4 Pt 1):1402-4. PubMed ID: 12352402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis.
    Steyerberg EW; Marshall PB; Keizer HJ; Habbema JD
    Cancer; 1999 Mar; 85(6):1331-41. PubMed ID: 10189139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
    Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
    Toyoshima Y; Hara T; Matsui Y; Nagumo Y; Maejima A; Shinoda Y; Komiyama M; Watanabe SI; Fujimoto H
    Ann Surg Oncol; 2018 Nov; 25(12):3668-3675. PubMed ID: 30191415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?
    Herr HW
    Br J Urol; 1997 Oct; 80(4):653-7. PubMed ID: 9352708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
    J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of testicular cancer with malignant transformation in the residual retroperitoneal mature teratoma 8 years after the initial chemotherapy].
    Ito K; Iigaya T; Umezawa A
    Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):622-6. PubMed ID: 9666691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections.
    Steyerberg EW; Keizer HJ; Stoter G; Habbema JD
    Eur J Cancer; 1994; 30A(9):1231-9. PubMed ID: 7999405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.
    Gels ME; Hoekstra HJ; Sleijfer DT; Nijboer AP; Molenaar WM; Ebels T; Schraffordt Koops H
    Chest; 1997 Oct; 112(4):967-73. PubMed ID: 9377960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.